HUMA

NASDAQ:HUMAW

Humacyte, Inc.

Add to Watchlist
  • Stock

1.41

−2.76%

−0.19

USD last updated 20/08 01:59:44

Last Close

1.59

19/08 22:25

Market Cap

681.16M

Beta: -

Volume Today

1.30M

Avg: -

PE Ratio

−3.64

PFCF: −4.65

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigation...Show More

    Earnings

    Earnings per Share (Estimate*)

    0.0020.0040.0060.0080.012022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    Revenue (Estimate*)

    0.000.000.010.010.012022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    *Estimate based on analyst consensus